Today more than ever, sustainability and ethical deployment of resources are key factors for investors. Our purpose in developing health technologies is to see those technologies used in rebuilding our communities, by supplementing state health infrastructure.
As a developer of technologies for the management and treatment of trauma related illnesses (including alcoholism, addiction, anxiety and PTSD) at a time where state health services are under resourced, and over burdened, BioPharm’s vision is to not only develop treatments and wellness enhancing technologies, but to also establish self funding community projects to enable members of low income demographics to access privately subsidised products and services to support their return to stable mental health.
The COVID pandemic followed by economic recession against a backdrop of eroded trust in government and state health services has set conditions for a global wave of mental health and trauma related conditions such as depression, anxiety, PTSD, alcoholism and other addictions. Public concern at novel pharmaceutical interventions employed has led a swing back to targeted natural health solutions.
BioPharm’s partnership with Everlasting Foundation, is committed to researching the most effective natural and nature inspired harm reduction technologies for trauma recovery, addiction interruption, cognitive restoration and all forms of drug detoxification. The partnership is committed to developing consumer level products targeted at those with disposable income, and subsidised or free on demand products for those of limited means.
Inspired by the hybrid limited partnership model of world leading software developer OpenAI, (developers of ChatGPT) BioPharm and Everlasting Foundation’s capped return offer aims to attract conscious investors with the oportunity to invest in a community asset, receive generous returns, with knowledge that in the long run you are establishing a self funded independant natural health provider.
To date formulations have been developed for alcohol cessation support, methamphetamine addiction recovery, opiate, cannabis and benzodiazepine drug withdrawal. The foundation intends to establish community centres to bring them to target audience, funded by ongoing operations.